PharmacoEconomics

, Volume 23, Issue 7, pp 743–744 | Cite as

The authors’ reply

  • Andrew Moore
  • Ceri Phillips
  • Elke Hunsche
  • James Pellissier
  • Simone Crespi
Correspondence
  • 19 Downloads

Keywords

Rheumatoid Arthritis Misoprostol Etoricoxib Claim Database Health Economic Analysis 

References

  1. 1.
    Moore A, Phillips C, Hunsche E, et al. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis in the UK. Pharmacoeconomics 2004; 22 (10): 643–60PubMedCrossRefGoogle Scholar
  2. 2.
    Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 1991; 18 Suppl. 28: 6–10Google Scholar
  3. 3.
    National Institute for Clinical Excellence. Guidance on the use Gasof cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis. Technology Appraisals Process Series No 27. London, England: NICE 2001 June Report No.: N0016Google Scholar
  4. 4.
    Hunt RH, Barkun AN, Baron D, et al. Recommendations for the appropriate use of anti-inflammatory drugs in the era of coxibs: defining the role of gastroprotective agents. Can J Gastroenterol 2002; 16 (4): 231–40PubMedGoogle Scholar
  5. 5.
    Maetzel A, Krahn M, Naglie G. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Arthritis Rheum 2003; 49 (3): 283–92PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Andrew Moore
    • 1
  • Ceri Phillips
    • 2
  • Elke Hunsche
    • 3
  • James Pellissier
    • 4
  • Simone Crespi
    • 5
  1. 1.Pain Research, The ChurchillHeadington, OxfordUK
  2. 2.School of Health and Science, Centre for Health Economics and Policy StudiesUniversity of Wales SwanseaSwansea, WalesUK
  3. 3.Outcomes Research, Merck & Co., Inc.Whitehouse StationUSA
  4. 4.Health Economic Statistics, Merck Research LaboratoriesMerck & Co., Inc.Blue BellUSA
  5. 5.Rutgers UniversityNew BrunswickUSA

Personalised recommendations